Exelixis | EXEL - Ebitda

株価
44.94
毎日の変更
-1.11 -2.41%
毎月
5.04%
毎年
20.06%
Q2 予測
43.98




Ebitda 変化する 日付
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.97B 457M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cytokinetics USD -277.18M 169.36M 2025-09
Eisai JPY 30.1B 6.62B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Genmab DKK 186M 291M 2025-12
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Incyte USD 414.5M 92.42M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck USD 8.39B 1.97B 2025-09
Moderna USD -790M 582M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Pfizer USD 6.08B 351M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Sanofi EUR 5.66B 3.77B 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Xencor USD -51.05M 55.28M 2025-12